ID   ADRM1_HUMAN             Reviewed;         407 AA.
AC   Q16186; A0PKB1; Q96FJ7; Q9H1P2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   07-APR-2021, entry version 187.
DE   RecName: Full=Proteasomal ubiquitin receptor ADRM1;
DE   AltName: Full=110 kDa cell membrane glycoprotein;
DE            Short=Gp110;
DE   AltName: Full=Adhesion-regulating molecule 1;
DE            Short=ARM-1;
DE   AltName: Full=Proteasome regulatory particle non-ATPase 13;
DE            Short=hRpn13;
DE   AltName: Full=Rpn13 homolog;
GN   Name=ADRM1; Synonyms=GP110;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8033103;
RA   Shimada S., Ogawa M., Takahashi M., Schlom J., Greiner J.W.;
RT   "Molecular cloning and characterization of the complementary DNA of an M(r)
RT   110,000 antigen expressed by human gastric carcinoma cells and upregulated
RT   by gamma-interferon.";
RL   Cancer Res. 54:3831-3836(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH PSMD1 AND UCHL5,
RP   SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16990800; DOI=10.1038/sj.emboj.7601338;
RA   Hamazaki J., Iemura S., Natsume T., Yashiroda H., Tanaka K., Murata S.;
RT   "A novel proteasome-interacting protein recruits the deubiquitinating
RT   enzyme UCH37 to 26S proteasomes.";
RL   EMBO J. 25:4524-4536(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH UCHL5, SUBCELLULAR LOCATION, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=17139257; DOI=10.1038/sj.emboj.7601450;
RA   Qiu X.-B., Ouyang S.-Y., Li C.-J., Miao S., Wang L., Goldberg A.L.;
RT   "hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the
RT   deubiquitinating enzyme, UCH37.";
RL   EMBO J. 25:5742-5753(2006).
RN   [6]
RP   FUNCTION, INTERACTION WITH 26S PROTEASOME, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16815440; DOI=10.1016/j.jmb.2006.06.011;
RA   Joergensen J.P., Lauridsen A.-M., Kristensen P., Dissing K., Johnsen A.H.,
RA   Hendil K.B., Hartmann-Petersen R.;
RT   "Adrm1, a putative cell adhesion regulating protein, is a novel proteasome-
RT   associated factor.";
RL   J. Mol. Biol. 360:1043-1052(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-217, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   FUNCTION, INTERACTION WITH PSMD1 AND UCHL5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16906146; DOI=10.1038/ncb1460;
RA   Yao T., Song L., Xu W., DeMartino G.N., Florens L., Swanson S.K.,
RA   Washburn M.P., Conaway R.C., Conaway J.W., Cohen R.E.;
RT   "Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme
RT   by Adrm1.";
RL   Nat. Cell Biol. 8:994-1002(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human 26S
RT   proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [10]
RP   FUNCTION, INTERACTION WITH UBIQUITIN, AND REGION.
RX   PubMed=18497817; DOI=10.1038/nature06926;
RA   Husnjak K., Elsasser S., Zhang N., Chen X., Randles L., Shi Y., Hofmann K.,
RA   Walters K.J., Finley D., Dikic I.;
RT   "Proteasome subunit Rpn13 is a novel ubiquitin receptor.";
RL   Nature 453:481-488(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211 AND THR-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND THR-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-127 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 1-407, INTERACTION WITH PSMD1, AND REGION.
RX   PubMed=20471946; DOI=10.1016/j.molcel.2010.04.019;
RA   Chen X., Lee B.H., Finley D., Walters K.J.;
RT   "Structure of proteasome ubiquitin receptor hRpn13 and its activation by
RT   the scaffolding protein hRpn2.";
RL   Mol. Cell 38:404-415(2010).
RN   [19]
RP   STRUCTURE BY NMR OF 270-407, INTERACTION WITH UCHL5, AND FUNCTION.
RX   PubMed=24752541; DOI=10.1007/s13238-014-0046-z;
RA   Jiao L., Ouyang S., Shaw N., Song G., Feng Y., Niu F., Qiu W., Zhu H.,
RA   Hung L.W., Zuo X., Eleonora Shtykova V., Zhu P., Dong Y.H., Xu R.,
RA   Liu Z.J.;
RT   "Mechanism of the Rpn13-induced activation of Uch37.";
RL   Protein Cell 5:616-630(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 266-388, INTERACTION WITH UCHL5,
RP   AND FUNCTION.
RX   PubMed=25702870; DOI=10.1016/j.molcel.2014.12.039;
RA   Sahtoe D.D., van Dijk W.J., El Oualid F., Ekkebus R., Ovaa H., Sixma T.K.;
RT   "Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in RPN13
RT   and INO80G.";
RL   Mol. Cell 57:887-900(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 285-386, INTERACTION WITH UCHL5,
RP   AND FUNCTION.
RX   PubMed=25702872; DOI=10.1016/j.molcel.2015.01.016;
RA   VanderLinden R.T., Hemmis C.W., Schmitt B., Ndoja A., Whitby F.G.,
RA   Robinson H., Cohen R.E., Yao T., Hill C.P.;
RT   "Structural basis for the activation and inhibition of the UCH37
RT   deubiquitylase.";
RL   Mol. Cell 57:901-911(2015).
RN   [22]
RP   STRUCTURE BY NMR OF 1-150, AND INTERACTION WITH UBIQUITIN AND UBQLN2.
RX   PubMed=27396824; DOI=10.1016/j.str.2016.05.018;
RA   Chen X., Randles L., Shi K., Tarasov S.G., Aihara H., Walters K.J.;
RT   "Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 reveal distinct binding
RT   mechanisms between substrate receptors and shuttle factors of the
RT   proteasome.";
RL   Structure 24:1257-1270(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated proteins.
CC       This complex plays a key role in the maintenance of protein homeostasis
CC       by removing misfolded or damaged proteins, which could impair cellular
CC       functions, and by removing proteins whose functions are no longer
CC       required. Therefore, the proteasome participates in numerous cellular
CC       processes, including cell cycle progression, apoptosis, or DNA damage
CC       repair. Within the complex, functions as a proteasomal ubiquitin
CC       receptor. Engages and activates 19S-associated deubiquitinases UCHL5
CC       and PSMD14 during protein degradation. UCHL5 reversibly associate with
CC       the 19S regulatory particle whereas PSMD14 is an intrinsic subunit of
CC       the proteasome lid subcomplex. {ECO:0000269|PubMed:16815440,
CC       ECO:0000269|PubMed:16906146, ECO:0000269|PubMed:16990800,
CC       ECO:0000269|PubMed:17139257, ECO:0000269|PubMed:18497817,
CC       ECO:0000269|PubMed:24752541, ECO:0000269|PubMed:25702870,
CC       ECO:0000269|PubMed:25702872}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle complex.
CC       The 26S proteasome consists of a 20S core particle (CP) and two 19S
CC       regulatory subunits (RP) (PubMed:16990800). Interacts with the
CC       proteasomal scaffolding protein PSMD1 (PubMed:16990800,PubMed:16815440,
CC       PubMed:16906146, PubMed:20471946). Interacts with deubiquitinase UCHL5;
CC       this interaction activates the auto-inhibited UCHL5 by deoligomerizing
CC       it (PubMed:17139257, PubMed:24752541, PubMed:25702870,
CC       PubMed:25702872). Interacts with UBQLN2 and ubiquitin
CC       (PubMed:27396824). {ECO:0000269|PubMed:16815440,
CC       ECO:0000269|PubMed:16906146, ECO:0000269|PubMed:16990800,
CC       ECO:0000269|PubMed:17139257, ECO:0000269|PubMed:18497817,
CC       ECO:0000269|PubMed:20471946, ECO:0000269|PubMed:24752541,
CC       ECO:0000269|PubMed:25702872, ECO:0000269|PubMed:27396824}.
CC   -!- INTERACTION:
CC       Q16186; Q99460: PSMD1; NbExp=5; IntAct=EBI-954387, EBI-357874;
CC       Q16186; Q13200: PSMD2; NbExp=3; IntAct=EBI-954387, EBI-357648;
CC       Q16186; P55036: PSMD4; NbExp=5; IntAct=EBI-954387, EBI-359318;
CC       Q16186; P54727: RAD23B; NbExp=2; IntAct=EBI-954387, EBI-954531;
CC       Q16186; P0CG48: UBC; NbExp=11; IntAct=EBI-954387, EBI-3390054;
CC       Q16186; Q9UMX0: UBQLN1; NbExp=4; IntAct=EBI-954387, EBI-741480;
CC       Q16186; Q9UHD9: UBQLN2; NbExp=5; IntAct=EBI-954387, EBI-947187;
CC       Q16186; Q9Y5K5: UCHL5; NbExp=21; IntAct=EBI-954387, EBI-1051183;
CC       Q16186; Q9Y5K5-3: UCHL5; NbExp=5; IntAct=EBI-954387, EBI-11749875;
CC       Q16186; P48510: DSK2; Xeno; NbExp=4; IntAct=EBI-954387, EBI-6174;
CC       Q16186; O35593: Psmd14; Xeno; NbExp=2; IntAct=EBI-954387, EBI-772796;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16990800}. Nucleus
CC       {ECO:0000269|PubMed:16990800}.
CC   -!- DOMAIN: The Pru (pleckstrin-like receptor for ubiquitin) domain
CC       mediates interactions with PSMD1 and ubiquitin. Preferential binding to
CC       the proximal subunit of K48-linked diubiquitin allows UCHL5 access to
CC       the distal subunit. {ECO:0000269|PubMed:18497817}.
CC   -!- SIMILARITY: Belongs to the ADRM1 family. {ECO:0000305}.
CC   -!- CAUTION: Although initially described as a cell membrane glycoprotein,
CC       ADRM1 is intracellular and non-glycosylated, and has probably no direct
CC       role in cell adhesion. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D64154; BAA11023.1; -; mRNA.
DR   EMBL; AL354836; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BR000321; FAA00246.1; -; mRNA.
DR   EMBL; BC010733; AAH10733.1; -; mRNA.
DR   EMBL; BC017245; AAH17245.1; -; mRNA.
DR   CCDS; CCDS13496.1; -.
DR   PIR; I52703; I52703.
DR   RefSeq; NP_001268366.1; NM_001281437.1.
DR   RefSeq; NP_001268367.1; NM_001281438.1.
DR   RefSeq; NP_008933.2; NM_007002.3.
DR   RefSeq; NP_783163.1; NM_175573.2.
DR   RefSeq; XP_005260314.1; XM_005260257.1.
DR   PDB; 2KQZ; NMR; -; A=253-407.
DR   PDB; 2KR0; NMR; -; A=1-407.
DR   PDB; 2L5V; NMR; -; A=260-407.
DR   PDB; 2MKZ; NMR; -; A=270-407.
DR   PDB; 2NBV; NMR; -; A=1-150.
DR   PDB; 4UEL; X-ray; 2.30 A; C=266-388.
DR   PDB; 4UEM; X-ray; 2.82 A; B=266-388.
DR   PDB; 4WLQ; X-ray; 2.85 A; B=286-384.
DR   PDB; 4WLR; X-ray; 2.00 A; B=285-386.
DR   PDB; 5IRS; X-ray; 1.80 A; A=2-150.
DR   PDB; 5V1Y; X-ray; 1.42 A; A/B=19-132.
DR   PDB; 5V1Z; X-ray; 2.00 A; A/B=19-132.
DR   PDB; 5YMY; NMR; -; C=1-150.
DR   PDB; 6CO4; NMR; -; A=1-150.
DR   PDB; 6OI4; X-ray; 1.76 A; A/B=20-132.
DR   PDB; 6UYI; NMR; -; A=1-150.
DR   PDB; 6UYJ; NMR; -; A=1-150.
DR   PDBsum; 2KQZ; -.
DR   PDBsum; 2KR0; -.
DR   PDBsum; 2L5V; -.
DR   PDBsum; 2MKZ; -.
DR   PDBsum; 2NBV; -.
DR   PDBsum; 4UEL; -.
DR   PDBsum; 4UEM; -.
DR   PDBsum; 4WLQ; -.
DR   PDBsum; 4WLR; -.
DR   PDBsum; 5IRS; -.
DR   PDBsum; 5V1Y; -.
DR   PDBsum; 5V1Z; -.
DR   PDBsum; 5YMY; -.
DR   PDBsum; 6CO4; -.
DR   PDBsum; 6OI4; -.
DR   PDBsum; 6UYI; -.
DR   PDBsum; 6UYJ; -.
DR   BMRB; Q16186; -.
DR   SMR; Q16186; -.
DR   BioGRID; 116235; 107.
DR   ComplexPortal; CPX-5993; 26S Proteasome complex.
DR   DIP; DIP-42668N; -.
DR   IntAct; Q16186; 68.
DR   MINT; Q16186; -.
DR   STRING; 9606.ENSP00000478877; -.
DR   ChEMBL; CHEMBL2364701; -.
DR   GlyGen; Q16186; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q16186; -.
DR   PhosphoSitePlus; Q16186; -.
DR   SwissPalm; Q16186; -.
DR   BioMuta; ADRM1; -.
DR   DMDM; 20141265; -.
DR   EPD; Q16186; -.
DR   jPOST; Q16186; -.
DR   MassIVE; Q16186; -.
DR   MaxQB; Q16186; -.
DR   PaxDb; Q16186; -.
DR   PeptideAtlas; Q16186; -.
DR   PRIDE; Q16186; -.
DR   ProteomicsDB; 60836; -.
DR   Antibodypedia; 29483; 297 antibodies.
DR   DNASU; 11047; -.
DR   Ensembl; ENST00000253003; ENSP00000253003; ENSG00000130706.
DR   Ensembl; ENST00000491935; ENSP00000478877; ENSG00000130706.
DR   GeneID; 11047; -.
DR   KEGG; hsa:11047; -.
DR   UCSC; uc002ycn.5; human.
DR   CTD; 11047; -.
DR   DisGeNET; 11047; -.
DR   GeneCards; ADRM1; -.
DR   HGNC; HGNC:15759; ADRM1.
DR   HPA; ENSG00000130706; Low tissue specificity.
DR   MIM; 610650; gene.
DR   neXtProt; NX_Q16186; -.
DR   OpenTargets; ENSG00000130706; -.
DR   PharmGKB; PA24599; -.
DR   VEuPathDB; HostDB:ENSG00000130706.12; -.
DR   eggNOG; KOG3037; Eukaryota.
DR   GeneTree; ENSGT00390000013839; -.
DR   HOGENOM; CLU_041798_2_0_1; -.
DR   InParanoid; Q16186; -.
DR   OMA; HCRRINE; -.
DR   OrthoDB; 1479349at2759; -.
DR   PhylomeDB; Q16186; -.
DR   TreeFam; TF313410; -.
DR   PathwayCommons; Q16186; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   BioGRID-ORCS; 11047; 237 hits in 998 CRISPR screens.
DR   ChiTaRS; ADRM1; human.
DR   EvolutionaryTrace; Q16186; -.
DR   GeneWiki; ADRM1; -.
DR   GenomeRNAi; 11047; -.
DR   Pharos; Q16186; Tbio.
DR   PRO; PR:Q16186; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q16186; protein.
DR   Bgee; ENSG00000130706; Expressed in gastrocnemius and 227 other tissues.
DR   ExpressionAtlas; Q16186; baseline and differential.
DR   Genevisible; Q16186; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IBA:GO_Central.
DR   GO; GO:0061133; F:endopeptidase activator activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0043248; P:proteasome assembly; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   DisProt; DP00839; -.
DR   Gene3D; 2.30.29.70; -; 1.
DR   Gene3D; 3.40.190.140; -; 1.
DR   IDEAL; IID00671; -.
DR   InterPro; IPR006773; Rpn13/ADRM1.
DR   InterPro; IPR038633; Rpn13/ADRM1_sf.
DR   InterPro; IPR032368; RPN13_C.
DR   InterPro; IPR038108; RPN13_C_sf.
DR   PANTHER; PTHR12225; PTHR12225; 1.
DR   Pfam; PF04683; Proteasom_Rpn13; 1.
DR   Pfam; PF16550; RPN13_C; 1.
DR   PROSITE; PS51916; DEUBAD; 1.
DR   PROSITE; PS51917; PRU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Proteasome; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..407
FT                   /note="Proteasomal ubiquitin receptor ADRM1"
FT                   /id="PRO_0000020631"
FT   DOMAIN          18..131
FT                   /note="Pru"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01265,
FT                   ECO:0000269|PubMed:18497817"
FT   DOMAIN          277..391
FT                   /note="DEUBAD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01264"
FT   REGION          253..407
FT                   /note="Interaction with UCHL5"
FT                   /evidence="ECO:0000269|PubMed:20471946"
FT   COMPBIAS        135..202
FT                   /note="Gly-rich"
FT   COMPBIAS        193..257
FT                   /note="Ser-rich"
FT   COMPBIAS        203..213
FT                   /note="Poly-Ser"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         15
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         127
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         217
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:23186163"
FT   MOD_RES         405
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JMB5"
FT   CROSSLNK        34
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT   CONFLICT        142
FT                   /note="S -> T (in Ref. 1; BAA11023)"
FT                   /evidence="ECO:0000305"
FT   STRAND          23..34
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          37..40
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          45..51
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          57..63
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   TURN            64..66
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          69..75
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          79..84
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          89..91
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          93..98
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   HELIX           99..101
FT                   /evidence="ECO:0007744|PDB:6OI4"
FT   STRAND          104..109
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   STRAND          111..114
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   HELIX           117..129
FT                   /evidence="ECO:0007744|PDB:5V1Y"
FT   TURN            191..195
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   STRAND          202..204
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   STRAND          249..253
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   TURN            254..256
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   HELIX           266..273
FT                   /evidence="ECO:0007744|PDB:2KQZ"
FT   STRAND          276..278
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   STRAND          282..284
FT                   /evidence="ECO:0007744|PDB:2KQZ"
FT   HELIX           288..291
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           294..297
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           300..302
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           304..310
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           311..313
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           324..326
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           327..332
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           334..348
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   TURN            349..351
FT                   /evidence="ECO:0007744|PDB:4UEM"
FT   HELIX           353..358
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           363..371
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   HELIX           374..383
FT                   /evidence="ECO:0007744|PDB:4WLR"
FT   STRAND          386..388
FT                   /evidence="ECO:0007744|PDB:2KR0"
FT   STRAND          395..397
FT                   /evidence="ECO:0007744|PDB:2MKZ"
SQ   SEQUENCE   407 AA;  42153 MW;  2D38811DCA231864 CRC64;
     MTTSGALFPS LVPGSRGASN KYLVEFRAGK MSLKGTTVTP DKRKGLVYIQ QTDDSLIHFC
     WKDRTSGNVE DDLIIFPDDC EFKRVPQCPS GRVYVLKFKA GSKRLFFWMQ EPKTDQDEEH
     CRKVNEYLNN PPMPGALGAS GSSGHELSAL GGEGGLQSLL GNMSHSQLMQ LIGPAGLGGL
     GGLGALTGPG LASLLGSSGP PGSSSSSSSR SQSAAVTPSS TTSSTRATPA PSAPAAASAT
     SPSPAPSSGN GASTAASPTQ PIQLSDLQSI LATMNVPAGP AGGQQVDLAS VLTPEIMAPI
     LANADVQERL LPYLPSGESL PQTADEIQNT LTSPQFQQAL GMFSAALASG QLGPLMCQFG
     LPAEAVEAAN KGDVEAFAKA MQNNAKPEQK EGDTKDKKDE EEDMSLD
//
